Redox modifications of protein-thiols: Emerging roles in cell signaling
Contribution of an unidentified sodium-dependent nucleoside transport system to the uptake and cytotoxicity of anthracycline in mouse M5076 ovarian sarcoma cells
Fibroblast heterogeneity in collagenolytic response to colchicine
Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells
Anti-Tat and anti-HIV activities of trimers of n -alkylglycines
Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes
Diethyl pyrocarbonate, a histidine-modifying agent, directly stimulates activity of ATP-sensitive potassium channels in pituitary GH3 cells
14-3-3ζ interacts with human thromboxane receptors and is involved in the agonist-induced activation of the extracellular-signal-regulated kinase
Inhibition of transcription factor NF-κB signaling proteins IKKβ and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
Niacin induces PPARγ expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways
Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases
N -(4-Trifluoromethylphenyl)amide group of the synthetic histamine receptor agonist inhibits nicotinic acetylcholine receptor-mediated catecholamine secretion
Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors
Proximal HNF1 element is essential for the induction of human UDP-glucuronosyltransferase 1A1 by glucocorticoid receptor
Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum
Corrigendum to “A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methods” [Biochem. Pharmacol. 70/9 (2005) 1343-1351],